CAS: 107097-80-3 - Loxiglumide
Formula:C21H30Cl2N2O5
InChI:InChI=1S/C21H30Cl2N2O5/c1-3-4-5-11-25(12-6-13-30-2)21(29)18(9-10-19(26)27)24-20(28)15-7-8-16(22)17(23)14-15/h7-8,14,18H,3-6,9-13H2,1-2H3,(H,24,28)(H,26,27)
InChI key:InChIKey=QNQZBKQEIFTHFZ-UHFFFAOYSA-N
SMILES:O=C(O)CCC(NC(=O)C1=CC=C(Cl)C(Cl)=C1)C(=O)N(CCCOC)CCCCC
- Synonyms:
- (+-)-4-((3,4-Dichlorobenzoyl)amino)-5-((3-methoxypropyl)pentylamino)-5-oxopentanoic acid
- (+-)-4-(3,4-Dichlorobenzamido)-N-(3-methoxypropyl)-N-pentylglutaramic acid
- Ccris 8590
- Cr 1505
- D,L-4-(3,4-Dichlorobenzoylamino)-5-(N-3-methoxypropylpentylamino)-5-oxo-pentanoic acid
- Loxiglumida
- Loxiglumida [Spanish]
- Loxiglumide [INN]
- Loxiglumidum
- Loxiglumidum [Latin]
- See more synonyms
- N~2~-(3,4-dichlorobenzoyl)-N-(3-methoxypropyl)-N-pentyl-alpha-glutamine
- Pentanoic acid, 4-((3,4-dichlorobenzoyl)amino)-5-((3-methoxypropyl)pentylamino)-5-oxo-, (+-)-
Brand | Product data | Purity | Price range | Estimated delivery |
---|---|---|---|---|
LOXIGLUMIDE REF: IN-DA008S1QCAS: 107097-80-3 | 97% | 116.00 €~471.00 € | Thu 05 Dec 24 | |
Loxiglumide REF: 7W-GK9118CAS: 107097-80-3 | - - - | To inquire | Tue 10 Dec 24 | |
Loxiglumide REF: TM-T2312CAS: 107097-80-3 | 98% - 99.81% | 34.00 €~883.00 € | Thu 12 Dec 24 | |
Loxiglumide REF: 3D-BL166440CAS: 107097-80-3 | Min. 95% | To inquire | Thu 16 Jan 25 |
LOXIGLUMIDE
CAS:107097-80-3
Formula:
C21H30Cl2N2O5
Purity:
97%
Color and Shape:
Solid
Molecular weight:
461.3793
Ref: IN-DA008S1Q
5mg | 116.00 € | ||
25mg | 199.00 € | ||
50mg | 276.00 € | ||
100mg | 471.00 € |
Estimated delivery in United States, on Thursday 5 Dec 2024
Loxiglumide
CAS:107097-80-3
Loxiglumide (CR-1505) is an antagonist of cholecystokinin (CCK-1) receptor.
Formula:
C21H30Cl2N2O5
Purity:
98% - 99.81%
Color and Shape:
Solid
Molecular weight:
461.38
Ref: TM-T2312
10mg | 40.00 € | ||
25mg | 76.00 € | ||
50mg | 120.00 € | ||
100mg | 196.00 € | ||
200mg | 337.00 € |
Estimated delivery in United States, on Thursday 12 Dec 2024
Ref: 3D-BL166440
10mg | To inquire | ||
50mg | To inquire |
Estimated delivery in United States, on Thursday 16 Jan 2025